Labocanna Spolka Akcyjna Logo

Labocanna Spolka Akcyjna

Cultivates and distributes medical marijuana and cannabinoid products for clinical and consumer use.

LCN | WAR

Overview

Corporate Details

ISIN(s):
PLCCTLS00017 (+1 more)
LEI:
259400GAPNZTGIR9PK55
Country:
Poland
Address:
KOSZALIN MIESZKA I 49, 75-129 KOSZALIN
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Labocanna S.A. is a company operating in the hemp industry, focused on the cultivation, production, and distribution of cannabis-derived products. Its primary strategic goal is to produce medical marijuana for patients and clinical use, leveraging indoor cultivation methods. The company is also involved in creating new compounds and mixtures based on cannabinoids such as CBD, CBG, and CBC for various applications, including consumer goods. Labocanna aims to build an integrated 'ecological hub' of firms within the hemp market, with plans to manage extensive cultivation areas through acquisitions and partnerships. Some sources also indicate the company has operations in commercial real estate management.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-02-09 17:33
Regulatory News Service
Zawarcie przedwstępnej umowy na import marihuany medycznej - Content (PL)
Polish 2.3 KB
2024-02-09 08:40
M&A Activity
Rozwiązanie Umowy Inwestycyjnej w sprawie połączenia ze spółką Foxbuy.com S.A. …
Polish 806 bytes
2024-01-24 17:56
Declaration of Voting Results & Voting Rights Announcements
Lista akcjonariuszy, którzy wzięli udział w Walnym Zgromadzeniu oraz mieli co n…
Polish 810 bytes
2024-01-18 08:46
Regulatory News Service
Otrzymanie pisma z Instytutu Weterynaryjnego - Państwowego Instytutu Badawczego…
Polish 874 bytes
2024-01-02 17:24
Regulatory News Service
Wygaśnięcie umowy o zachowaniu poufności - Content (PL)
Polish 654 bytes
2023-12-28 17:28
Proxy Solicitation & Information Statement
Formularz dla pełnomocnika
Polish 133.8 KB
2023-12-28 17:28
Pre-Annual General Meeting Information
Proponowane zmiany statutu Labocanna S.A.
Polish 183.6 KB
2023-12-28 17:28
Pre-Annual General Meeting Information
Projekty uchwał na NWZA Labocanna S.A.
Polish 221.4 KB
2023-12-28 17:28
Pre-Annual General Meeting Information
Ogłoszenie o NWZA Labocanna S.A.
Polish 99.3 KB
2023-12-28 17:28
Pre-Annual General Meeting Information
ogłoszenie o zwołaniu NWZ na dzień 24 stycznia 2024 r. wraz z projektami uchwał…
Polish 469 bytes
2023-12-28 16:49
Major Shareholding Notification
Lista akcjonariuszy, którzy wzięli udział w Walnym Zgromadzeniu oraz mieli co n…
Polish 603 bytes
2023-12-20 18:02
Share Issue/Capital Change
Założenie spółki zależnej - Content (PL)
Polish 1.0 KB
2023-12-01 15:37
Proxy Solicitation & Information Statement
Formularz dla pełnomocnika na NWZA
Polish 132.6 KB
2023-12-01 15:37
Registration Form
Proponowane zmiany statutu na NWZA
Polish 204.9 KB
2023-12-01 15:37
Post-Annual General Meeting Information
Projekty uchwła na NWZA
Polish 246.8 KB

Automate Your Workflow. Get a real-time feed of all Labocanna Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Labocanna Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Labocanna Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Eisai Co., Ltd. Logo
A global, research-based pharmaceutical firm that develops and markets prescription and OTC drugs.
Japan 4523
Elicera Therapeutics AB Logo
Develops CAR T-cell & oncolytic virus therapies for cancer, enhanced by its iTANK platform.
Sweden ELIC
Ellen AB Logo
Develops research-based probiotic and prebiotic products for women's intimate health and pH balance.
Sweden ELN
Enlivex Therapeutics Ltd. Logo
Developing cell therapy to restore immune balance for inflammatory diseases like sepsis.
Israel ENLV
Enorama Pharma AB Logo
Develops & makes consumer nicotine products & medicated gums, offering private label solutions.
Sweden ERMA
Develops novel therapeutics and APIs for oncology, inflammation, and respiratory diseases.
South Korea 183490
Enzymatica AB Logo
Develops medical devices with patented enzyme technology to treat upper respiratory infections.
Sweden ENZY
Developing alopecia therapies, skin regeneration products, and preclinical CRO services.
South Korea 446440
EQL Pharma AB Logo
Develops and sells cost-efficient niche generic medicines for the Nordic healthcare market.
Sweden EQL
ERYTECH Pharma S.A. Logo
Developing phage therapies to combat antibiotic-resistant bacterial infections.
France ERYP

Talk to a Data Expert

Have a question? We'll get back to you promptly.